No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
US Stock MarketDetailed Quotes
HRMY Harmony Biosciences
- 34.280
- +0.390+1.15%
Close Dec 20 16:00 ET
- 34.280
- 0.0000.00%
Post 16:20 ET
1.96BMarket Cap16.25P/E (TTM)
34.970High33.480Low2.98MVolume33.480Open33.890Pre Close102.02MTurnover6.76%Turnover Ratio16.09P/E (Static)57.03MShares41.61052wk High3.28P/B1.51BFloat Cap28.14052wk Low--Dividend TTM44.06MShs Float62.085Historical High--Div YieldTTM4.40%Amplitude18.611Historical Low34.273Avg Price1Lot Size
Full Hours
- 5D
- Daily
- Weekly
- Monthly
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
H.C. Wainwright Maintains Harmony Biosciences(HRMY.US) With Buy Rating, Maintains Target Price $75
Harmony Biosciences Analyst Ratings
H.C. Wainwright Initiates Harmony Biosciences(HRMY.US) With Buy Rating, Announces Target Price $75
Express News | Harmony Biosciences : H.c. Wainwright Initiates Coverage With Buy Rating; Target Price $75
Piper Sandler Maintains Harmony Biosciences(HRMY.US) With Buy Rating, Raises Target Price to $48
Dyne, Avidity Initiated at Outperform by RBC on DM1 Drugs
Heat List
US
Overall
Symbol
Price
% Chg
No Data